Congenital adrenal hyperplasia with a CYP21A2 deletion overlapping the tenascin-X gene: an atypical presentation

J Pediatr Endocrinol Metab. 2022 Oct 20;36(1):81-85. doi: 10.1515/jpem-2022-0396. Print 2023 Jan 27.

Abstract

Objectives: Congenital Adrenal Hyperplasia (CAH) is a group of genetic diseases characterized by impaired cortisol biosynthesis. 95% of CAH cases result from mutation in the CYP21A2 gene encoding 21-hydroxilase. TNX-B gene partially overlaps CYP21A2 and encodes a matrix protein called Tenascin-X (TNX). Complete tenascin deficiency causes Enlers-Danlos syndrome (EDS). A mono allelic variant called CAH-X CH-1 was recently described, resulting from a CYP21A2 complete deletion that extends into the TNXB. This haploinsufficiency of TNX may be associated with a mild hypermobility form of EDS, as well as other connective tissue comorbidities such as hernia, cardiac defects and chronic arthralgia.

Case presentation: We report four patients heterozygous for a CAH-X CH-1 allele that do not present clinical manifestations of the EDS.

Conclusions: All CAH patients, carriers of these TNXA/TNXB chimeras, should be evaluated for clinical manifestations related to connective tissue hypermobility, cardiac abnormalities and other EDS features, allowing for better clinical surveillance management.

Keywords: CAH-X syndrome; CYP21A2 gene; tenascin-X.

Publication types

  • Case Reports

MeSH terms

  • Adrenal Hyperplasia, Congenital* / complications
  • Ehlers-Danlos Syndrome* / complications
  • Ehlers-Danlos Syndrome* / diagnosis
  • Ehlers-Danlos Syndrome* / genetics
  • Humans
  • Mutation
  • Steroid 21-Hydroxylase / genetics
  • Tenascin / genetics
  • Tenascin / metabolism

Substances

  • tenascin X
  • Tenascin
  • Steroid 21-Hydroxylase
  • TNXA protein, human
  • CYP21A2 protein, human

Supplementary concepts

  • Congenital adrenal hyperplasia due to 21 hydroxylase deficiency